Life Line Screening - Scientific Advisory Network*
*Participants provide research guidance and leadership involving the Life Line Screening Database and do not receive financial support or endorse any product or service

Jeffrey S. Berger, MD, MS, FAHA, FACC

Assistant Professor of Medicine (Cardiology and Hematology)
Assistant Professor of Surgery (Vascular Surgery)
Director of Cardiovascular Thrombosis
New York University School of Medicine

Richard Bulbulia MA MD FRCS

Consultant Vascular Surgeon
Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU)
Nuffield Department of Population Health
University of Oxford

Michael S. Conte, MD

Professor and Chief, Division of Vascular and Endovascular Surgery
Co-Director, Heart and Vascular Center
University of California, San Francisco

Professor Alison Halliday MS FRCS

Professor of Vascular Surgery
University of Oxford

George S. Lavenson, Jr., MD

Independent Vascular Surgeon
Volunteer and Member, Society for Vascular Surgery
Adjunct Professor of Surgery at the Uniformed Services University, Bethesda, Maryland

Sarah Lewington BSc MSc DPhil

MRC Investigator Scientist
Scientific Director, MSc Global Health Sciences
Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU)
Nuffield Department of Population Health
University of Oxford, UK

Thomas S Riles, MD

Frank C. Spencer Professor of Surgery
Associate Dean of Medical Education and Technology
Departments of Surgery and Administration
NYU Vascular Surgery Associates

Caron Rockman MD, FACS, RVT

Associate Professor of Surgery
Director of Clinical Research
Division of Vascular and Endovascular Surgery
Department of Surgery
New York University Medical Center

Richard Stein, MD

Professor; Assoc. Director of Cardiology Consult Services
Department of Medicine (Cardio Division)
NYU Cardiology Associates
NYU Cardiac Rehab Associates

Life Line Screening – Research Portal

Life Line Screening is the nation’s leading provider of high quality, community-based, preventive health screenings. Since its establishment in 1993, Life Line Screening has screened nearly 8 million people, with almost 1 million individuals being screened each year. In this effort, it has accumulated one of the largest databases of information on health outcomes and associated behaviors.

Life Line Screening is committed to research that can answer important health questions and is pleased to make available data and resources to investigators studying chronic diseases and their management. Life Line Screening’s resources provide an important advance in answering questions about health-related behavior and modifiable risk factors in subpopulations that could not be previously examined due to size limitations of studies such as the Framingham Heart Study.